Crk-associated substrate lymphocyte type (Cas-L) is a docking protein that is heavily tyrosine phosphorylated by the engagement of b1 integrins in T cells. In the present study, we attempted to evaluate the role of Cas-L in the pathophysiology of adult T-cell leukemia (ATL). Examination of peripheral blood mononuclear cells from ATL patients as well as ATL-derived T cell lines showed an elevation of Cas-L in these cells. We showed that tyrosine phosphorylation as well as expression of Cas-L was markedly elevated through the induction of human Tlymphotropic virus type I (HTLV-I) Tax in JPX-9 cells, with these cells showing marked motile behavior on the ligands for integrins. We next performed yeast two-hybrid screening of cDNA library from an HTLV-I-transformed T cell line, which resulted in the identification of Tax as a putative binding partner for Cas-L. Co-precipitation experiments revealed that the serine-rich region of Cas-L might serve as the binding site with the highest affinity for Tax. Co-localization study showed that Tax and Cas-L partly merged in the cytoplasm. Finally, we showed that exogenous Cas-L inhibited Tax-mediated transactivation of nuclear factor jB (NF-jB), while Tax-independent activation of NF-jB remained intact, hence indicating that Cas-L might specifically regulate Tax-NF-jB pathway.
Introduction
It has been shown that b1 integrins exhibit a variety of biological functions such as cytokine production, proliferation, cell differentiation, cell survival, apoptosis, and cell migration as well as cell adhesion through specific interaction with their ligands (extracellular matrix and vascular cell adhesion molecule (VCAM)-1) (Hemler, 1990; Hynes, 1992; Juliano and Haskill, 1993; Ruoslahti and Reed, 1994) . To understand the molecular mechanisms involved with these numerous biological effects, it is particularly important to analyse cell signaling through the b1 integrins. In this regard, we demonstrated that interaction of FN and very late antigen (VLA)-5 or the CS-1 domain of FN and VLA-4 could induce costimulatory signals to CD3/TCR pathway (Matsuyama et al., 1989; Nojima et al., 1990) . Our subsequent study showed that PLC-g, FAK (focal adhesion kinase), paxillin, fyn, lck, ERK1/2, and pp105 were tyrosine-phosphorylated upon engagement of b1 integrins in T cells (Nojima et al., 1992; Sato et al., 1995; Tachibana et al., 1995) . Isolation of cDNA encoding pp105 revealed that this protein belonged to Cas family, and we designated it Cas-L (Cas lymphocyte type) (Law et al., 1996; Minegishi et al., 1996) .
Cas-L is a docking protein that is heavily tyrosine phosphorylated by FAK and Src family kinases upon engagement of b1 integrins as well as the TCR complex in T cells (Tachibana et al., 1997; Ohashi et al., 1998) . Cas-L cDNA was cloned initially from adult T-cell leukemia (ATL)-derived T cell lines, and its expression was markedly elevated in those cells (Minegishi et al., 1996) . Recently, we have demonstrated that Cas-L was overexpressed and tyrosine phosphorylated in vivo in human T-lymphotropic virus type I (HTLV-I) Tax transgenic mice (Miyake-Nishijima et al., 2003) . These facts led us to evaluate the possible biological link among Cas-L, Tax, and HTLV-I-related disorders.
It is known that HTLV-I is the etiologic agent for ATL (Uchiyama et al., 1977; Yodoi and Uchiyama, 1986; Yoshida, 1993) . One of the characteristics of this malignancy is the infiltration of leukemic T cells into the skin and other organs. Although the precise mechanism of pathogenesis of ATL remains unclear, p40 tax protein is thought to play a key role in HTLV-I-mediated transformation of T cells (Yoshida, 1993) . Tax, encoded by the pX region of the HTLV-I genome, is a potent transactivator of various host genes as well as HTLV-I LTR-mediated transcription of the viral genome (Sodroski et al., 1984) . Tax activates transcription of numerous host cellular genes associated with lymphocyte proliferation, for examples, proto-oncogenes (Fujii et al., 1991) , cytokines and cytokine receptors including IL-2R (Inoue et al., 1986; Maruyama et al., 1987; Cross et al., 1987) , c-fos (Fujii et al., 1988; Nagata et al., 1989) , TGF-b (Kim et al., 1990) , gp34/OX-40/CD134 (Miura et al., 1991) , IL-6 (Yamashita et al., 1994) , TNF-a (Albrecht et al., 1992) , IL-8 (Mori et al., 1998) , as well as the integrated provirus of HTLV-I (Sodroski et al., 1984) . These findings suggest its close association with T-cell immortalization and transformation. It has been shown that this transactivation of host genes is mediated through the interaction of p40 tax with several cellular transcription factors, such as cyclic AMP-responsive element binding protein/activating transcriptional factor (CREB/ATF), NF-kB, and serum responsive factor (SRF) (Yoshimura et al., 1990; Yoshida, 1993; Franchini, 1995; Harhaj and Sun, 1999) .
In this paper, we demonstrate the possible involvement of Cas-L in the pathogenesis of ATL through Taxmediated overexpression and hyper-phosphorylation of Cas-L, which resulted in markedly enhanced motility of lymphocytes. Furthermore, we showed that the interaction of Tax and Cas-L may result in the modulation of Tax-mediated transactivation of NF-kB.
Results

Predominant expression of Cas-L in HTLV-Itransformed T cell lines and ATL-derived T cell lines
We previously described and cloned pp105/Cas-L in ATL-derived T cell lines H9 (Nojima et al., 1992; Minegishi et al., 1996) . In those cells, higher levels of Cas-L protein and mRNA were observed than unstimulated peripheral T cells. To investigate the distribution of Cas-L, a variety of HTLV-I-transformed T cell lines, ATL-derived T cell lines, and HTLV-I-unrelated T cell lines were examined for expression of Cas-L as well as FAK, Pyk2 (FAK-related tyrosine kinase), paxillin, and HTLV-I Tax. As shown in Figure 1 , the expression of Cas-L was higher in the cases of HTLV-I-transformed T cell lines (MT-1, MT-2, and MT-4) and ATLderived T cell lines (Hut-102, H9, and SLB-I) than HTLV-I-unrelated T cell lines (Jurkat and HPB-ALL). In contrast, expression of FAK, Pyk2, and paxillin, which are also involved in b1 integrin-mediated cell signaling, did not exhibit such distribution pattern among these T cell lines.
Elevation in protein level and tyrosine phosphorylation level of Cas-L and other related signal-transducing proteins downstream of b1 integrins in Tax-induced JPX-9 cells
Since our results showed that ATL-derived and HTLV-I transformed T cell lines expressed Cas-L at higher levels, we hypothesize that HTLV-I Tax protein might cause the preferential overproduction of Cas-L in HTLV-I-infected T cell lines. We examined the expression of Cas-L in JPX-9 cells and JPX-M cells, in which Tax protein is induced by a metallothionein promoter (Nagata et al., 1989) . JPX-M cells were used as negative controls, in which inactive mutant Tax protein was induced by the same stimuli. As shown in Figure 2a , Cas-L protein level was elevated in JPX-9 cells in a timedependent manner after the addition of CdCl 2 , whereas control JPX-M cells stimulated in the same condition did not show any alteration in Cas-L level.
We next compared the expression of Cas-L and other proteins involved in b1 integrin-mediated signaling by immunoprecipitation and immunoblotting. As shown in Figure 2b , the levels of FAK, paxillin, and Cas-L were also elevated following induction of Tax in JPX-9 cells. Surprisingly, levels of spontaneous tyrosine phosphorylation of Cas-L, FAK, Pyk2, and paxillin were also elevated by induction of Tax. In contrast, the levels of protein expression and tyrosine phosphorylation of these proteins were not altered in JPX-M cells.
Enhanced motility of Tax-induced JPX-9 cells
We previously reported that gene transfer of Cas-L provided Jurkat cells with motile behavior on FN-, CD3-plus FN-, and CS-1-coated surface, and that this enhancement of motility required the tyrosine phosphorylation of Cas-L (Ohashi et al., 1999) . We therefore evaluated the motility of JPX-9 cells and JPX-M cells on CS-1-coated Transwellt insert. As shown in Figure 3a , Possible involvement of Cas-L in pathophysiology of ATL S Iwata et al JPX-9 cells stimulated with CdCl 2 displayed remarkable motility compared to unstimulated JPX-9 cells. In the control JPX-M cells, such promotion of motility by induction of Tax was not observed. As shown in the figure, the enhanced motility observed in Tax-induced JPX-9 cells was comparable to Hut-102, SLB-I, and MT-2, which showed higher motility than HTLV-Iunrelated T cell lines (Jurkat and HPB-ALL). To further characterize the cell motility observed in the Tax-and Cas-L induced JPX-9 cells, we transduced dominantnegative Cas-L (DSD and DC) or FAK-CT constructs by retroviral gene transfer. As shown in Figure 3b , gene transfer of these constructs resulted in the reduced induction of motility on CD3 plus FN-coated surface, indicating that Tax-mediated enhancement of T cell motility was at least partly mediated through b1 integrins-Cas-L pathway.
Enhanced expression and tyrosine phosphorylation of Cas-L in PBMCs from ATL patients
To further explore the clinical relevance of Cas-L overproduction in HTLV-I-related diseases, we obtained samples from ATL patients as well as asymptomatic HTLV-I carriers. As shown in Figure 4 , mononuclear cells from the peripheral blood of ATL patients had elevated expression of Cas-L in four of five cases examined. Interestingly, the levels of tyrosine phosphorylation of Cas-L were clearly elevated in two of those cases (#4 and #8). In contrast, neither overproduction of Cas-L nor enhanced phosphorylation of Cas-L was observed in the cases with asymptomatic HTLV-I carriers. Thus, overproduction of Cas-L and, in some cases, elevation of its tyrosine phosphorylation was also observed in ATL patients.
Identification of Tax as a putative Cas-L binding protein
To further understand the biological significance of Cas-L in ATL and HTLV-I related disorders, we next performed two-hybrid cDNA cloning in search for Cas-L binding proteins. We screened over 1 Â 10 6 indepen- 
Co-precipitation of Cas-L and p130Cas with Tax
To evaluate protein-protein interaction of Cas-L and Tax, we performed co-precipitation experiments using 293T cells. Initially, we employed full-length constructs for Cas-L and p130Cas, another Cas family member. As shown in Figure 5a , transfected Cas-L was co-precipitated with Tax in those cells. Since p130Cas was the first reported Cas family protein with well-conserved domain structures, we performed the same studies as those done with Cas-L, and found that p130Cas was similarly coprecipitated with Tax. We also performed the co-precipitation experiments using MT-2 and Hut-102 cells that co-express Cas-L and Tax. As shown in Figure 5b , Cas-L protein was coprecipitated with Tax in those cells, suggesting that endogenous Cas-L and Tax associated with each other in HTLV-I-infected T cell lines.
Determination of Tax-binding domains of Cas-L
To identify the Tax-binding domain of Cas-L, we first employed a series of deletion mutants: Cas-LDSH3: lacking SH3 domain (aa 1-60); DSD: lacking substrate domain (aa 63-401); and DC: lacking c-terminal half (aa 406-834). We also prepared a point mutant Cas-LF, in which the Src-SH2-binding motif YDYVHL was mutated to FDFVHL (Tachibana et al., 1997) . The structures of these mutants were schematically summarized in Figure 5c . Unexpectedly, none of these mutations or deletions could abolish the binding capability of Cas-L with Tax in 293T cells (Figure 5d ), implying multiple binding sites were present in Cas-L, as was suggested in the case involving the association of Cas-L/HEF1 and Smad3 (Liu et al., 2000) . We then produced GST-fusion protein of each domain. As shown in Figure 5e , SR or SRF had equivalent and the strongest binding capability. In addition, SD and HLH showed significant binding with Tax, whereas SH3 showed no binding capability.
Co-localization of Cas-L with Tax in the cytosol of transfected 293T, MT-2, and Hut-102 cells
We next determined the co-localization of Cas-L with Tax by confocal microscopy. As shown in Figure 6A , transfected c-myc-tagged Cas-L alone mainly localized in the cytosol (column a, row 2), which was not altered by the co-transfection of Tax (column a, row 1). In contrast, transfected Tax localized both in the nucleus and cytosol (nucleus dominant; column b, row 3), which was changed to a cytosol dominant pattern (column b, row 2). This alteration of subcellular localization was observed especially in cells co-expressing Cas-L and Tax (column c, row 1). Furthermore, Cas-L and Tax were mainly co-localized in the cytosol (column c, row 1). Similar results were also observed in the cases with Hut-102 and MT-2 cells, in which Cas-L and Tax proteins were endogenously co-expressed ( Figure 6B ). These results suggest that Cas-L and Tax possibly cooperate by protein-protein interaction mainly in the cytosol.
Exogenous Cas-L interferes with Tax-mediated transactivation of NF-kB
Tax is known as a potent transcriptional activator of host genes flanked by kB sequences as well as HTLV-I LTR. We examined the effect of Cas-L on Taxassociated kB-or TRE-dependent transactivation. As shown in Figure 7a , co-transfected Cas-L partially, but potently, inhibited Tax-mediated activation of an NF-kB-dependent transcription. This inhibitory activity was observed in all deletion mutants examined (Cas-LF, DSH3, DC, DSD), although the activity was weakest in Cas-LDC, which is consistent with the co-immunoprecipitation assay (Figure 5d and e) . On the other hand, Tax-mediated transcriptional enhancement of TRE-luciferase was not altered (Figure 7b ). To assess the specificity of inhibition of kB-driven transcriptional activation, we next examined the effect of Cas-L on TNF-a (on 293T cells) or PMA (on Jurkat T cells)-stimulated activation of NF-kB. As shown in Figure 7c and d, expression of Cas-L or p130Cas did not affect NF-kB activation by these stimuli. These results strongly suggest that exogenous Cas-L specifically interferes with Tax-mediated activation of NF-kB. 
Discussion
In the present study, we have shown that HTLV-I Tax may induce the expression and tyrosine phosphorylation of Cas-L. Using Jurkat T cells, we previously showed that gene transfer of Cas-L promoted cell motility on the ligands for b1 integrins (i.e. FN and CS-1) in the presence or absence of anti-CD3 mAb stimulation (Ohashi et al., 1999) . This enhancement was dependent on tyrosine phosphorylation of Cas-L, since the phosphorylation-deficient mutant of Cas-L (DSH3 and DSD) failed to enhance cell migration. Tax-induced JPX-9 cells clearly exhibited elevated level of tyrosine phosphorylation as well as elevated expression level of Cas-L. These findings are of special interest since leukemic cells in ATL are notorious for extensive infiltrative activity toward organs and tissues, contributing to the unique clinical features of ATL (Uchiyama, 1996) . A variety of molecules involved in cellular adhesion and migration are thought to play important roles in ATL pathophysiology, including MMP-9 (Mori et al., 2002) , OX-40 (Imura et al., 1996) , b1 integrins (especially VLA-4) (Ishikawa et al., 1993) , and L-selectins (Ishikawa et al., 1993) . Our current results imply that Cas-L may be one of targets for therapeutic intervention through modulation of its overexpression or tyrosine phosphorylation. Our results that the dominant-negative Cas-L mutants and FAK-CT inhibited Tax-mediated increase in cell motility indicating the involvement of Cas-L. However, it is still possible that some other Tax-inducible genes such as those described above might be involved in this phenomenon. The precise mechanism by which Cas-L was tyrosinephosphorylated through the expression of Tax is an important question that remains to be elucidated. It should be noted that the expression levels of Tax and Cas-L did not perfectly correlate in HTLV-Itransformed T cell lines and ATL-derived (MT-1 and H9) and patients samples from ATL. Indeed, in those clinical samples, the expression of Tax was hardly detected by immunoblotting (data not shown). This was consistent with the report that expression of Tax and viral mRNAs is tightly regulated in vivo by HTLV-I itself to escape from host defense mechanisms involving cytotoxic T lymphocytes reactive for Tax and env protein of HTLV-I (Yoshida, 1993) . Therefore, the possibility exists that other undefined factors may contribute to the elevated expression of Cas-L in vivo.
In this study, we identified Tax as one of the Cas-L binding molecules. Others and we have shown that Cas family proteins contain common structural motifs (Sakai et al., 1994; Ishino et al., 1995; Alexandropoulos and Baltimore, 1996; Law et al., 1996; Minegishi et al., 1996) . It has been reported that some classes of Taxbinding proteins have coiled-coil domain, through which they associate with the same domain of Tax (Chun et al., 2000) . Unexpectedly, SR showed the strongest affinity for Tax, while SD and HLH only displayed some affinity. The significance of the interaction between Tax and these domains, especially in tyrosine phosphorylation of Cas-L, remains unclear. This important issue will be a main focus in future experiments.
To explore the effect of Tax-Cas-L interaction, we next analysed Tax-dependent transcriptional activation. Tax is a potent transactivator of numerous host genes besides being a cis-activator of the HTLV-I long terminal repeat. Among them, we compared the effect of Cas-L on NF-kB (Tax-dependent and Tax-independent) and TRE, and our results indicated that Cas-L may selectively interfere with Tax-mediated transactivation of NF-kB pathway. Due to methodological limitations involving the use of patient samples and HTLV-I infected cells that endogenously co-express Cas-L and Tax, we employed Jurkat T cells, which do not have detectable Tax expression and low level of Cas-L expression. Since the luciferase assay is a transient expression system, there is a possibility that Cas-Lmediated inhibition of NF-kB transactivation by Tax might reflect an artifact of overexpression. However, based on the findings that overexpression of Cas-L did not significantly alter other stimulatory signals that also induce NF-kB pathway (PMA, TNF-a), we believe that the observed phenomenon may still be biologically relevant.
Evaluating potential mechanisms by which Cas-L partially suppresses the Tax-mediated transactivation of NF-kB, we presented data suggesting that subcellular distribution of Tax was altered by the co-expression of Cas-L. Another possibility is that Cas-L may interact with other components of the NF-kB signaling pathway. Among them, IKK-a and IKK-b are known to possess HLH, through which they may associate with Cas family proteins. The possible interaction between Cas family members and IKK proteins and its impact on Tax-mediated transactivation remain to be solved in future.
In the clinical setting, our results that Cas-L might inhibit Tax-mediated transactivation of NF-kB appear to be contrary to the findings that Tax-mediated induction of Cas-L might be responsible for the invasive behavior of leukemic cells in ATL.
Our working hypothesis is that Cas-L may be a negative feedback regulator of the Tax/NF-kB system, potentially analogous to its role in the TGF-b/Smad system (Liu et al., 2000) . In the TGF-b/Smad system, Cas-L inhibits Smad3-mediated signaling by TGF-b by acting as a cytosolic sequestering protein for Smad3. On the other hand, it has been shown recently that TGF-b induces Cas-L (Zheng and McKeown-Longo, 2002) .
Another possible interpretation is that induction of Cas-L by Tax might be a double-edged sword, since suppression of NF-kB-mediated transcription acts against leukemogenesis, whereas enhancement of cell motility contributes to the invasive nature of leukemic cells, which results in the complex clinical course of ATL as described above. Indeed, the clinical course of ATL is atypical in that the duration from viral infection to the clinical manifestation of leukemia often spans several decades.
In light of the fact that NF-kB is constitutively active in HTLV-I-transformed cells and ATL-derived T cell lines, which show also elevated Cas-L expression and Tax, it is possible that Cas-L-mediated suppression of transactivation by Tax might be overcome by unknown mechanisms during leukemogenesis. The discrepancy remains to be solved as a future question. Understanding the ontogeny of expression of Tax and Cas-L in vivo remains a difficult but critical point for evaluating the role of Cas-L in cellular transformation.
Together with previous results, the present findings suggest that Cas-L protein plays a crucial role in the pathophysiology of ATL. Additional investigations focusing on these new findings may lead to the eventual development of possible therapeutic applications of Cas-L gene products in HTLV-I-related diseases in the future.
Materials and methods
Antibodies and reagents
Anti-phosphotyrosine antibody (4G10) was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY, USA). MAbs against FAK, Pyk2/CAKb, p130Cas, and paxillin were obtained from Transduction Laboratories (Lexington, KY, USA). A rabbit polyclonal Ab (pAb) against Cas-L was described previously (Ohashi et al., 1998) . All chemicals were purchased from Sigma Chemical Co. (St Louis, MO, USA) unless otherwise stated. Mab against Tax (MI73) was kindly provided by Dr S. Yamaoka (Tokyo Medical and Dental University, Japan). Mab against c-myc tag (9E10) was produced from the hybridoma obtained from American Type Culture Collection (Manassas, VA, USA).
Plasmids pCDSRa-CasL, pCDSRa-c-myc-Cas-L, pMT3-c-myc-Cas-L, pCDRSRa-p130Cas were described elsewhere (Tachibana et al., 1997) . The expression construct pCDSRa-c-mycCasLDSH3 lacks aa 1-60, pCDSRa-c-myc-CasLDSD lacks aa 63-401, pCDSRa-c-myc-CasLDC lacks aa 406-834 of Cas-L, respectively. In pCDSRa-c-myc-CasLF, Y629 and Y631 were mutated into F. pH2Rneo, pH2Rneo-wtTAX and pH2Rneo-40MTAX were kindly provided by Dr S Yamaoka (Tanaka et al., 1990) . promoter (Nagata et al., 1989) . For the induction of Tax, the cells were cultured with 10 mM of CdCl 2 .
Human peripheral blood mononuclear cells (PBMC) were isolated from heparinized blood of healthy volunteer donors, HTLV-I infected individuals, and patients with ATL by FicollHypaque density-gradient centrifugation, and washed with PBS. The diagnosis of ATL was based on clinical features, hematologic findings, and the presence of anti-HTLV-I antibodies in patient sera. All clinical samples were collected after informed consent was obtained.
Retroviral gene transfer
pMX-IRES-GFP and Plat-E were kindly provided by Dr T Kitamura (The Institute of Medical Science, The University of Tokyo, Japan) (Morita et al., 2000) . C-myc-tagged Cas-LDSD, Cas-LDC, and FAKCT (aa 709-1052) were subcloned into pMX-IRES-GFP. Plat-E cells were transfected using the Fugene6 reagent (Roche Applied Science, Indianapolis, IN, USA) with 1 mg of each retroviral vector. In total, 48 h posttransfection, the viral supernatant was used to infect PT-67 amphotropic packaging cell line (BD Biosciences Clontech, Palo Alto, CA, USA). After establishing PT-67 derived cell line stably producing each retrovirus, the supernatant was collected and used to infect JPX-9 cells at 321C. After appropriate time period, GFP-positive cells were sorted by EPICS ELITE (Beckman Coulter, Inc., Tokyo, Japan).
Migration assays
Migration of JPX-9 cells was assayed using Transwellt inserts with polycarbonate filter as described previously (Ohashi et al., 1999) . CS-1/GST fusion protein was described previously (Iwata et al., 2002) . The Transwell chambers containing 100 ml of 10 6 cells were inserted into wells filled with 600 ml of 0.6% BSA RPMI1640. After incubation at 371C, the filters were stained with May-Giemsa solutions. The number of migrated cells to the lower side of the filters was counted microscopically in five high-power fields per insert at Â 400 magnification. Each experiment was performed in triplicate wells.
Immunoprecipitation and immunoblotting
For immunoprecipitation, cells were lysed in 1% Triton X-100 lysis buffer (Iwata et al., 2002) . Briefly, cellular lysates were incubated with appropriate first Ab at 41C overnight, and then with protein A sepharose beads for 4 h. The beads were washed with 1% Triton X-100 lysis buffer, and heated to 951C in the SDS-PAGE loading buffer. The supernatants were loaded onto 8% SDS-PAGE gels, electro-transferred onto PVDF membranes. After blocking, membranes were incubated with the primary Ab, then washed and incubated with HRPconjugated anti-mouse IgG Ab. The membranes were developed by the enhanced chemiluminescence (ECL) system (Amersham Biosciences, Piscataway, NJ, USA).
Yeast two-hybrid screening
The two-hybrid analysis was carried out essentially as described previously (Durfee et al., 1993) , using pACTII (for GAL4 activator domain) and pBTM116 (for LexA DNAbinding domain). cDNA encoding full-length Cas-L was cloned into pBTM116. The resulting plasmid, pBTM116-Cas-L, was used as bait in a two-hybrid screen of a cDNA library of human HTLV-I infected T cell line (SLB-I) (BD Biosciences Clontech) in S. cerevisiae L40. Positive yeast clones were selected for histidine prototrophy and expression of b-galactosidase. Plasmids containing cDNA clones were rescued from yeast and characterized by DNA sequencing.
Immunofluorescence and confocal microscopy
Transfected cells cultured on the glass coverslips were fixed by immersion in 3.7% PBS-paraformaldehyde solution for 10 min, and permeabilized with PBS-0.1% Triton X-100 for 10 min. After blocking with 1% BSA-PBS, slips were incubated with the primary antibodies for 1 h, then washed and incubated with Cy3-, Texas Red-or FITC-conjugated appropriate second antibodies for one additional hour. After washing, slips were mounted and observed using an argonkrypton laser confocal microscope (FV500, OLYMPUS, Tokyo, Japan).
GST-pull down assay
The coding regions for Cas-L SH3 (aa 1-77), SD (substrate domain) (aa 62-359), SR (serine-rich region) (aa 350-639), CC (coiled-coil domain) (aa 635-700), HLH (helix-loop-helix domain) (aa 678-775), or CC/HLH/CT (c-terminal region) (aa 635-834) were PCR-amplified and subcloned into the pGEX-2 T vector. GST-SRF contains aa 350-639 of Cas-L with Y629F and Y631F mutation. GST or GST-Cas-L domains expressed in E. coli were purified by adsorption to glutathione sepharose 4B beads. Those proteins preimmobilized on 5 ml of 50% slurry of the brads were incubated with cellular lysates from Tax-transfected 293T cells (50 mg total protein) for 4 h at 41C. Following incubation, the bound matrices were washed with 1% Triton X-100 lysis buffer, and then subjected to 12% SDS-PAGE and immunoblotting, as described.
Transfection and luciferase assay
Transfection and Luciferase reporter assay were performed as described previously with some modification (Iwata et al., 2002) . Briefly, Dual-Luciferaset Reporter Assay System (Promega, Madison, WI, USA) was used to measure Luciferase activity expressed by the experimental plasmids pNF-kB-Luc (Stratagene, La Jolla, CA, USA) and pHTLVLuc (TRE-Luc). pNF-kB-Luc has 5 Â tandem repeat of kB enhancer element and pHTLV-Luc contains 1-650 bp of HTLV-I LTR (U3-R part of U5). For the internal control, pRL-TK was employed. The enzyme activities of firefly luciferase and Renilla luciferase were measured by luminometer (Model TD-20/20, Turner Design, Inc., Sunnyvale, CA, USA).
